Health ❯ Biotechnology ❯ Drug Development

Clinical Trials

Safety Concerns Innovation Challenges NLRP3 Inhibitors AI Applications Oncology Cancer Treatment Monoclonal Antibodies Weight Maintenance MC4R-deficient Genetic Obesity Market Analysis Sustained Release Technology Innovative Therapies Pancreatic Cancer

FDA Approves Isembyld, First Muscle‑Directed Therapy for Spinal Muscular Atrophy

Isembyld is an IV add‑on to existing SMN2 treatments that showed motor improvement in children and will begin U.S. shipments.

Senhwa Signs MOU With GEM for Up to NT$500 Million to Speed AI-Driven Cancer R&D

Sanofi Secures Global Rights to ADEL’s Alzheimer’s Antibody in Deal Worth Up to $1.04 Billion